Intracoronary Autologous Cardiac Progenitor Cell Transfer in Patients With Hypoplastic Left Heart Syndrome (TICAP): A Prospective Phase 1 Controlled Trial | Journal Scan

Study Questions:

What is the safety and feasibility of intracoronary delivery of autologous cardiosphere-derived cells (CDCs) in patients with hypoplastic left heart syndrome (HLHS)?